IsoPlexis to Participate in Three Upcoming Investor Conferences
BRANFORD, Conn., Feb. 11, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today announced the company will be participating in the following investor conferences.
- 11th Annual SVB Leerink Global Healthcare Conference, Virtual
Fireside Chat on Wednesday, February 16th at 7:00 a.m. Pacific Time / 10:00 a.m. Eastern Time - Cowen 42nd Annual Health Care Conference, Virtual
Fireside Chat on Wednesday, March 9th at 6:10 a.m. Pacific Time / 9:10 a.m. Eastern Time - Barclays Global Healthcare Conference
Fireside Chat on Tuesday, March 15th at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time
Interested parties may access live and archived webcasts on the “Investors” section of the company website at: www.isoplexis.com.
About IsoPlexis
IsoPlexis is the Superhuman Cell company.
IsoPlexis’ systems uniquely identify a comprehensive range of multifunctional single cells, i.e. the superhero cells in the human body. These cells enable researchers to understand and predict disease progression, treatment resistance and therapeutic efficacy to advance all of human health.
IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies and at two-thirds of leading U.S. comprehensive cancer centers.
Investor Contact
investors@isoplexis.com
Press Contact
press@isoplexis.com
